{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:00:13Z","timestamp":1772676013109,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The American Diabetes Association (ADA) recommends screening for prediabetes and diabetes (dysglycemia) starting at age 35, or younger than 35 years among adults with overweight or obesity and other risk factors. Diabetes risk differs by sex, race, and ethnicity, but performance of the recommendation in these sociodemographic subgroups is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Nationally representative data from the National Health and Nutrition Examination Surveys (2015-March 2020) were analyzed from 5,287 nonpregnant US adults without diagnosed diabetes. Screening eligibility was based on age, measured body mass index, and the presence of diabetes risk factors. Dysglycemia was defined by fasting plasma glucose \u2265100mg\/dL (\u22655.6 mmol\/L) or haemoglobin A1c \u22655.7% (\u226539mmol\/mol). The sensitivity, specificity, and predictive values of the ADA screening criteria were examined by sex, race, and ethnicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>An estimated 83.1% (95% CI=81.2-84.7) of US adults were eligible for screening according to the 2023 ADA recommendation. Overall, ADA\u2019s screening criteria exhibited high sensitivity [95.0% (95% CI=92.7-96.6)] and low specificity [27.1% (95% CI=24.5-29.9)], which did not differ by race or ethnicity. Sensitivity was higher among women [97.8% (95% CI=96.6-98.6)] than men [92.4% (95% CI=88.3-95.1)]. Racial and ethnic differences in sensitivity and specificity among men were statistically significant (<jats:italic>P<\/jats:italic>=0.04 and <jats:italic>P<\/jats:italic>=0.02, respectively). Among women, guideline performance did not differ by race and ethnicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The ADA screening criteria exhibited high sensitivity for all groups and was marginally higher in women than men. Racial and ethnic differences in guideline performance among men were small and unlikely to have a significant impact on health equity. Future research could examine adoption of this recommendation in practice and examine its effects on treatment and clinical outcomes by sex, race, and ethnicity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1279348","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:25:22Z","timestamp":1697181922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical performance and health equity implications of the American Diabetes Association\u2019s 2023 screening recommendation for prediabetes and diabetes"],"prefix":"10.3389","volume":"14","author":[{"given":"Matthew J.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy C.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald T.","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed K.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"McKeever Bullard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet."},{"key":"B2","unstructured":"Prevalence of prediabetes among adults. U.S. Department of health & Human services"},{"key":"B3","unstructured":"Prevalence of both diagnosed and undiagnosed diabetes. U.S. Department of health & Human services"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1226","article-title":"The economic burden of elevated blood glucose levels in 2017: Diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes","volume":"42","author":"Dall","year":"2019","journal-title":"Diabetes Care Sep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002","article-title":"Standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110572","article-title":"Impact of changes in diabetes screening guidelines on testing eligibility and potential yield among adults without diagnosed diabetes in the United States","volume":"197","author":"Ali","year":"2023","journal-title":"Diabetes Res Clin Pract Mar"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.4945","article-title":"Age at diagnosis of diabetes by race and ethnicity in the United States from 2011 to 2018","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14590","article-title":"Trends in obesity prevalence by race and hispanic origin-1999-2000 to 2017-2018","volume":"324","author":"Ogden","year":"2020","journal-title":"JAMA. Sep 22"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/hco.0000000000000742","article-title":"Hypertension and race\/ethnicity","volume":"35","author":"Deere","year":"2020","journal-title":"Curr Opin Cardiol Jul"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100175","article-title":"Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States","volume":"6","author":"Katz","year":"2021","journal-title":"Am J Prev Cardiol Jun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4939-5","article-title":"Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course","volume":"62","author":"Huebschmann","year":"2019","journal-title":"Diabetologia. Oct"},{"key":"B13","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2015-2016","author":"Hales","year":"2017","journal-title":"NCHS Data Brief. Oct"},{"key":"B14","unstructured":"NHANES survey methods and analytic guidelines. U.S. Department of health & Human services"},{"key":"B15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-publhealth-040218-044158","article-title":"The next generation of diabetes translation: A path to health equity","volume":"40","author":"Haire-Joshu","year":"2019","journal-title":"Annu Rev Public Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05245-7","article-title":"National survey of primary care physicians' Knowledge, practices, and perceptions of prediabetes","volume":"9","author":"Tseng","year":"2019","journal-title":"J Gen Intern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.01.007","article-title":"Screening for prediabetes and diabetes: Clinical performance and implications for health equity","volume":"64","author":"O'Brien","year":"2023","journal-title":"Am J Prev Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"B19","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.296962","article-title":"The national glycohemoglobin standardization program: Over 20 years of improving hemoglobin A(1c) measurement","volume":"65","author":"Little","year":"2019","journal-title":"Clin Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA. Jun 7"},{"key":"B23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev Jun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/nu11071580","article-title":"Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults","volume":"11","author":"Wei","year":"2019","journal-title":"Nutrients."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2313-3","article-title":"Do men develop type 2 diabetes at lower body mass indices than women","volume":"54","author":"Logue","year":"2011","journal-title":"Diabetologia."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1847","article-title":"Trends in the prevalence of lean diabetes among U.S. Adults, 2015-2020","volume":"46","author":"Adesoba","year":"2023","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7217","article-title":"Trends in gestational diabetes at first live birth by race and ethnicity in the US, 2011-2019","volume":"326","author":"Shah","year":"2021","journal-title":"JAMA."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2391","article-title":"BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening","volume":"38","author":"Hsu","year":"2015","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2071","article-title":"Optimum BMI cut points to screen Asian Americans for type 2 diabetes","volume":"38","author":"Araneta","year":"2015","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight - reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-8-199610150-00008","article-title":"The medicalization of race: scientific legitimization of a flawed social construct","volume":"125","author":"Witzig","year":"1996","journal-title":"Ann Intern Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.08.009","article-title":"High agreement of self-report and physician-diagnosed somatic conditions yields limited bias in examining mental-physical comorbidity","volume":"63","author":"Baumeister","year":"2010","journal-title":"J Clin Epidemiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030422","article-title":"Type 1 diabetes mellitus and autoimmune diseases: A critical review of the association and the application of personalized medicine","volume":"13","author":"Popoviciu","year":"2023","journal-title":"J Pers Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2337\/cd21-0039","article-title":"Increasing diabetes screening in a primary care setting","volume":"40","author":"Iyengar","year":"2022","journal-title":"Clin Diabetes. Jan"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2133","article-title":"An interrupted time series analysis to determine the effect of an electronic health record-based intervention on appropriate screening for type 2 diabetes in urban primary care clinics in New York City","volume":"40","author":"Albu","year":"2017","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1279348\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:25:26Z","timestamp":1697181926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1279348\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":35,"alternative-id":["10.3389\/fendo.2023.1279348"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1279348","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"article-number":"1279348"}}